Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7710)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 14, 2021 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Niu XK, He XF. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma. World J Gastroenterol 2021; 27(2): 189-207 [PMID: 33510559 DOI: 10.3748/wjg.v27.i2.189] |
|---|---|
| URL: | https://www.wjgnet.com/2218-6190/full/v27/i2/189.htm |
| Number | Citing Articles |
| 1 |
Jie Peng, Jinhua Huang, Guijia Huang, Jing Zhang. Predicting the Initial Treatment Response to Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma by the Integration of Radiomics and Deep Learning. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.730282
|
| 2 |
Cyra Y Kang, Samantha E Duarte, Hye Sung Kim, Eugene Kim, Jonghanne Park, Alice Daeun Lee, Yeseul Kim, Leeseul Kim, Sukjoo Cho, Yoojin Oh, Gahyun Gim, Inae Park, Dongyup Lee, Mohamed Abazeed, Yury S Velichko, Young Kwang Chae. Artificial Intelligence-based Radiomics in the Era of Immuno-oncology. The Oncologist 2022; 27(6): e471 doi: 10.1093/oncolo/oyac036
|
| 3 |
Wei-Li Xia, Shi-Jun Xu, Yuan Guo, Xiao-Hui Zhao, Hong-Tao Hu, Yan Zhao, Quan-Jun Yao, Lin Zheng, Dong-Yang Zhang, Chen-Yang Guo, Wei-Jun Fan, Hai-Liang Li. Plasma arginase-1 as a predictive marker for early transarterial chemoembolization refractoriness in unresectable hepatocellular carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1014653
|
| 4 |
Zhiyuan Bo, Jiatao Song, Qikuan He, Bo Chen, Ziyan Chen, Xiaozai Xie, Danyang Shu, Kaiyu Chen, Yi Wang, Gang Chen. Application of artificial intelligence radiomics in the diagnosis, treatment, and prognosis of hepatocellular carcinoma. Computers in Biology and Medicine 2024; 173: 108337 doi: 10.1016/j.compbiomed.2024.108337
|
| 5 |
Qifan He, Jian Yang, Yonghai Jin. Development and Validation of TACE Refractoriness-Related Diagnostic and Prognostic Scores and Characterization of Tumor Microenvironment Infiltration in Hepatocellular Carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.869993
|
| 6 |
Vincenza Granata, Roberta Fusco, Sergio Venazio Setola, Igino Simonetti, Diletta Cozzi, Giulia Grazzini, Francesca Grassi, Andrea Belli, Vittorio Miele, Francesco Izzo, Antonella Petrillo. An update on radiomics techniques in primary liver cancers. Infectious Agents and Cancer 2022; 17(1) doi: 10.1186/s13027-022-00422-6
|
| 7 |
Dan-Dan Wang, Jin-Feng Zhang, Lin-Han Zhang, Meng Niu, Hui-Jie Jiang, Fu-Cang Jia, Shi-Ting Feng. Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study. Hepatobiliary & Pancreatic Diseases International 2023; 22(6): 594 doi: 10.1016/j.hbpd.2022.11.005
|
| 8 |
Chun Jiang, Yi-Qi Cai, Jia-Jia Yang, Can-Yu Ma, Jia-Xi Chen, Lan Huang, Ze Xiang, Jian Wu. Radiomics in the diagnosis and treatment of hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2023; 22(4): 346 doi: 10.1016/j.hbpd.2023.03.010
|
| 9 |
Sonia Triggiani, Maria T. Contaldo, Giulia Mastellone, Maurizio Cè, Anna M. Ierardi, Gianpaolo Carrafiello, Michaela Cellina.
The Role of Artificial Intelligence and Texture Analysis in Interventional Radiological Treatments of Liver Masses: A Narrative Review
. Critical Reviews™ in Oncogenesis 2024; 29(2): 37 doi: 10.1615/CritRevOncog.2023049855
|
| 10 |
Natally Horvat, Joao Miranda, Maria El Homsi, Jacob J. Peoples, Niamh M. Long, Amber L. Simpson, Richard K. G. Do. A primer on texture analysis in abdominal radiology. Abdominal Radiology 2021; 47(9): 2972 doi: 10.1007/s00261-021-03359-3
|
| 11 |
Gang Peng, Xiao-yu Huang, Ya-nan Wang, Xiao-jing Cao, Xiang Zhou. Prognostic Value of Preoperative MRI-derived 3D Quantitative Tumor Arterial Burden in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization. Radiology: Imaging Cancer 2024; 6(3) doi: 10.1148/rycan.230167
|
| 12 |
Faraaz Khan, Keaton Jones, Paul Lyon. Immune checkpoint inhibition: a future guided by radiology. The British Journal of Radiology 2023; doi: 10.1259/bjr.20220565
|
| 13 |
Na Zhang, Xiao-Feng He, Xiang-Ke Niu. Mapping research trends of transarterial chemoembolization for hepatocellular carcinoma from 2012 to 2021: A bibliometric analysis. World Journal of Methodology 2023; 13(4): 345-358 doi: 10.5662/wjm.v13.i4.345
Abstract(332) |
Core Tip(242) |
Full Article(HTML)(822)
|
Full Article with Cover (PDF)-36372K(55)
|
Full Article (Word)-8711K(37)
|
Audio-5356K(2)
|
Peer-Review Report-256K(26)
|
Answering Reviewers-356K(29)
|
Supplementary Material-341K(35)
|
Full Article (PDF)-36160K(65)
|
Full Article (XML)-129K(26)
|
Times Cited (0)
|
Total Visits (2764)
|
Open
|
| 14 |
Jia-Wei Zhong, Dan-Dan Nie, Ji-Lan Huang, Rong-Guang Luo, Qing-He Cheng, Qiao-Ting Du, Gui-Hai Guo, Liang-Liang Bai, Xue-Yun Guo, Yan Chen, Si-Hai Chen. Prediction model of no-response before the first transarterial chemoembolization for hepatocellular carcinoma: TACF score. Discover Oncology 2023; 14(1) doi: 10.1007/s12672-023-00803-2
|
| 15 |
Tian-You Chen, Zong-Guo Yang, Ying Li, Mao-Quan Li. Radiomic advances in the transarterial chemoembolization related therapy for hepatocellular carcinoma. World Journal of Radiology 2023; 15(4): 89-97 doi: 10.4329/wjr.v15.i4.89
|
| 16 |
Yanmei Dai, Huijie Jiang, Shi-Ting Feng, Yuwei Xia, Jinping Li, Sheng Zhao, Dandan Wang, Xu Zeng, Yusi Chen, Yanjie Xin, Dongmin Liu. Noninvasive Imaging Evaluation Based on Computed Tomography of the Efficacy of Initial Transarterial Chemoembolization to Predict Outcome in Patients with Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 273 doi: 10.2147/JHC.S351077
|
| 17 |
Tianhao Cong, Chao Yang, Qi Cao, Jinrui Ren, Yingen Luo, Pei Yuan, Bo Zheng, Yu Liu, Hongcai Yang, Wendi Kang, Aixin Ou, Xiao Li. The Role of GNMT and MMP12 Expression in Determining TACE Efficacy: Validation at Transcription and Protein Levels. Journal of Hepatocellular Carcinoma 2024; : 95 doi: 10.2147/JHC.S441179
|
| 18 |
Jingwei Wei, Hanyu Jiang, Yu Zhou, Jie Tian, Felipe S. Furtado, Onofrio A. Catalano. Radiomics: A radiological evidence-based artificial intelligence technique to facilitate personalized precision medicine in hepatocellular carcinoma. Digestive and Liver Disease 2023; 55(7): 833 doi: 10.1016/j.dld.2022.12.015
|
| 19 |
Vincenza Granata, Roberta Grassi, Roberta Fusco, Andrea Belli, Carmen Cutolo, Silvia Pradella, Giulia Grazzini, Michelearcangelo La Porta, Maria Chiara Brunese, Federica De Muzio, Alessandro Ottaiano, Antonio Avallone, Francesco Izzo, Antonella Petrillo. Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma. Infectious Agents and Cancer 2021; 16(1) doi: 10.1186/s13027-021-00393-0
|
| 20 |
Yuze Li, Ziming Xu, Chao An, Huijun Chen, Xiao Li. Multi-Task Deep Learning Approach for Simultaneous Objective Response Prediction and Tumor Segmentation in HCC Patients with Transarterial Chemoembolization. Journal of Personalized Medicine 2022; 12(2): 248 doi: 10.3390/jpm12020248
|
| 21 |
Cody Criss, Arpit M Nagar, Mina S Makary. Hepatocellular carcinoma: State of the art diagnostic imaging. World Journal of Radiology 2023; 15(3): 56-68 doi: 10.4329/wjr.v15.i3.56
|
| 22 |
Xiang-Ke Niu, Xiao-Feng He. A Nomogram Based on Preoperative Lipiodol Deposition after Sequential Retreatment with Transarterial Chemoembolization to Predict Prognoses for Intermediate-Stage Hepatocellular Carcinoma. Journal of Personalized Medicine 2022; 12(9): 1375 doi: 10.3390/jpm12091375
|